Loading...
•
Sep 30, 2021
Teladoc Q3 2021 Earnings Report
Teladoc Health's third quarter earnings increased as revenue grew year-over-year and total visits increased.
Key Takeaways
Teladoc Health reported strong third-quarter results with revenue growing 81% year-over-year to $522 million. Total third quarter visits topped 3.9 million, a 37% increase from Q3 2020. The company updated its 2021 revenue outlook to $2,015 million to $2,025 million.
Third quarter revenue grew 81% year-over-year to $522 million.
Total third quarter visits topped 3.9 million – 37% higher than Q3 2020.
New agreements with CVS Health and Centene to provide Teladoc Health’s Primary360.
Teladoc Health ranked 1st in consumer satisfaction by J.D. Power 2021 U.S. Telehealth Satisfaction Study.
Revenue by Geographic Location
Forward Guidance
Teladoc Health provides guidance based on current market conditions and expectations. For the fourth-quarter 2021, we expect: Total revenue to be in the range of $536 million to $546 million.
Positive Outlook
- Total revenue to be in the range of $536 million to $546 million.
- EBITDA to be in the range of $(8) million to $(3) million.
- Adjusted EBITDA to be in the range of $69 million to $74 million.
- Net loss per share, based on 160 million weighted average shares outstanding, to be between $(0.73) and $(0.53).
- Total U.S. paid membership to be in the range of 52.5 million to 53.5 million members and visit fee only access to be available to approximately 23 million to 24 million individuals.
Challenges Ahead
- Net loss per share, based on 160 million weighted average shares outstanding, to be between $(0.73) and $(0.53).
- EBITDA to be in the range of $(8) million to $(3) million.
- Total revenue to be in the range of $2,015 million to $2,025 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...